Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 08:54 am Purchase | 2024-09-30 | 13G | Merus N.V. MRUS | Deerfield Mgmt, L.P. | 3,408,539 4.980% | 388,638 (+12.87%) | Filing History |
| 2024-11-14 08:54 am Purchase | 2024-09-30 | 13G | MALLINCKRODT PLC SHS MNKTQ | Deerfield Mgmt, L.P. | 1,460,233 7.410% | 179,000 (+13.97%) | Filing History |
| 2024-11-14 08:53 am Unchanged | 2024-09-30 | 13G | Windtree Therapeutics, Inc. WINT | Deerfield Mgmt, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-12 6:58 pm Purchase | 2024-11-06 | 13G | Oscar Health, Inc. OSCR | Deerfield Mgmt, L.P. | 11,835,000 5.590% | 588,180 (+5.23%) | Filing History |
| 2024-11-08 4:49 pm Purchase | 2024-11-01 | 13G | Lomond Therapeutics Holdings, Inc. | Deerfield Mgmt, L.P. | 2,692,625 9.900% | 2,692,625 (New Position) | Filing History |
| 2024-11-01 7:54 pm Unchanged | 2024-10-31 | 13D | Singular Genomics Systems, Inc. OMIC | Deerfield Mgmt, L.P. | 249,495 6.660% | 0 (Unchanged) | Filing History |
| 2024-10-25 5:45 pm Purchase | 2024-10-18 | 13G | Embecta Corp. EMBC | Deerfield Mgmt, L.P. | 3,075,335 5.330% | 3,075,335 (New Position) | Filing History |
| 2024-09-20 6:00 pm Purchase | 2024-09-13 | 13G | Foghorn Therapeutics Inc. FHTX | Deerfield Mgmt, L.P. | 2,935,295 5.310% | 2,935,295 (New Position) | Filing History |
| 2024-09-12 4:07 pm Purchase | 2024-09-05 | 13D | Singular Genomics Systems, Inc. OMIC | Deerfield Mgmt, L.P. | 249,495 6.660% | 249,495 (New Position) | Filing History |
| 2024-07-11 6:47 pm Purchase | 2024-07-09 | 13D | BiomX Inc. PHGE | Deerfield Mgmt, L.P. | 15,558,445 9.990% | 14,947,435 (+2446.35%) | Filing History |
| 2024-05-30 7:26 pm Unchanged | 2024-05-30 | 13D | BiomX Inc. PHGE | Deerfield Mgmt, L.P. | 611,010 8.750% | 0 (Unchanged) | Filing History |
| 2024-05-17 5:14 pm Purchase | 2024-05-07 | 13G | Alignment Healthcare, Inc. ALHC | Deerfield Mgmt, L.P. | 10,865,513 5.680% | 10,865,513 (New Position) | Filing History |
| 2024-05-15 6:39 pm Purchase | 2024-05-15 | 13G | Nuvalent, Inc. NUVL | Deerfield Mgmt, L.P. | 25,579,890 33.990% | 102,114 (+0.40%) | Filing History |
| 2024-04-24 5:50 pm Purchase | 2024-04-18 | 13G | Cullinan Therapeutics, Inc. CGEM | Deerfield Mgmt, L.P. | 3,283,824 5.710% | 3,283,824 (New Position) | Filing History |
| 2024-04-04 12:52 pm Purchase | 2024-03-15 | 13G | Ventyx Biosciences, Inc. VTYX | Deerfield Mgmt, L.P. | 3,542,000 5.030% | 3,542,000 (New Position) | Filing History |
| 2024-03-22 5:44 pm Purchase | 2024-03-15 | 13D | BiomX Inc. PHGE | Deerfield Mgmt, L.P. | 611,010 11.060% | 611,010 (New Position) | Filing History |
| 2024-03-15 4:37 pm Purchase | 2024-03-14 | 13D | Larimar Therapeutics, Inc. LRMR | Deerfield Mgmt, L.P. | 21,273,474 33.320% | 8,300 (+0.04%) | Filing History |
| 2024-02-16 2:11 pm Purchase | 2024-02-16 | 13D | Larimar Therapeutics, Inc. LRMR | Deerfield Mgmt, L.P. | 21,265,174 34.820% | 4,291,539 (+25.28%) | Filing History |
| 2024-02-15 5:20 pm Unchanged | 2024-02-13 | 13D | Larimar Therapeutics, Inc. LRMR | Deerfield Mgmt, L.P. | 16,973,635 39.200% | 0 (Unchanged) | Filing History |
| 2024-02-12 5:34 pm Purchase | 2023-12-31 | 13G | Nuvalent, Inc. NUVL | Deerfield Mgmt, L.P. | 25,477,776 35.010% | 6,110 (+0.02%) | Filing History |